Echo-int Co., Ltd.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
Echo-in’s core products focus on specialized ultrasound AI solutions, mainly including the EchoVIU Expert Platform series: EchoVIU-Liver, an AI-assisted system developed for liver disease diagnosis, supporting conditions such as fatty liver, non-alcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis, and liver cancer; EchoVIU Expert Ultrasound Platform, a no-code AI ultrasound solution enabling medical professionals to easily use AI technology; and SUDA Expert AI, a professional ultrasound AI system with a no-code interface to simplify workflow for medical staff. Technical advantages include specialized ultrasound optimization for specific medical fields, integration of advanced machine learning algorithms with AI, and clinically oriented design providing key information beyond imaging diagnosis. Target clients are primarily hospitals, clinical doctors, and related medical professionals, aiming to improve diagnostic efficiency and accuracy while promoting precision medicine.
Founded Year
2011
Unified Business No.
53348368
Status
Active
Number of Employees
18
Total Paid-in
Capital
31,500,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Echo-int is an innovative company specializing in medical AI technologies, guided by the core philosophy of “Beyond Imaging, Becoming the Physician’s Best Partner for Accurate Diagnosis.” Founded in June 2011, the company develops specialty ultrasound systems using software algorithms and AI to achieve digital health goals, providing clinicians with diagnostic information beyond traditional imaging and significantly enhancing efficiency and accuracy. Echo-int has established a unique technological advantage in medical imaging AI, focusing on specialty ultrasound solutions, with outstanding performance in liver disease diagnosis. Echo-int has secured multiple trademarks, including its flagship product “EchoVIU,” and continues to invest in research and innovation, positioning itself as a key player in Taiwan’s medical AI field.
